11 17 WPI (Mirtazapine 15 mg)
Pill imprint 11 17 WPI has been identified as Mirtazapine 15 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; post traumatic stress disorder; hot flashes and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 11 17 WPI (Mirtazapine 15 mg)
- 15 mg
- 10.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
|NDC Code||Manufacturer / Repackager|
|63874-1098||Altura Pharmaceuticals Inc (repackager)|
|58016-0894||Southwood Pharmaceuticals Inc (repackager)|
|16590-0153||Stat RX USA LLC (repackager)|
|68258-7004||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Mirtazapine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...